Each ALG attorney has been practicing law for at least 10 years and has an advanced scientific degree and/or significant research experience in academia or industry. Each is admitted to practice law in California and is registered to practice before the United States Patent and Trademark Office.
Dan owns the Acuity Law Group, which succeeds the BioTechnology Law Group, which he founded in May 2002 after more than 10 years of practicing as an attorney in both corporate and law firm settings. He has been registered to practice before the U.S. Patent and Trademark Office since 1990, and he is admitted to practice law in California. He has extensive legal experience relating to patents, opinion letters, and licensing. His research experience draws from his training in biology (BA; University of California, Los Angeles (1985)) and more than four years of molecular biology-based research in academia (UCLA and Duke, 1985-1988) and industry (Amgen, 1988-1989).
With regard to patents, Dan has substantial experience in various fields relevant to biotechnology and pharmaceuticals, including molecular biology, biochemistry, immunology, gene therapy, and chemistry, as well as other technology areas, principally medical devices and automotives. His clients have included Amgen, where he served first as a patent agent and then as corporate counsel; Viagene, where he was the Company’s sole in-house attorney, GeneFormatics, where he served as Vice President, Intellectual Property and then as General Counsel, as well as SUGEN, Gen-Probe, Geron, Biosite, Wyntek Diagnostics, Lpath, and Cardiothoracic Systems, which he represented while in private practice at Lyon & Lyon and Brobeck, Phleger & Harrison. In this context, he has provided the full range of services, from implementing invention identification and tracking mechanisms to counseling inventors, drafting and prosecuting patent applications (including interference practice), and handling post-issuance proceedings.
In addition to his extensive prosecution experience, Dan has also prepared many patentability, non-infringement, validity, and freedom-to-operate opinions. He also is available to mediate patent-related disputes, either before or after litigation has commenced, and he has also served as a patent expert in litigation.
Dan also has extensive experience in licensing matters, ranging from assisting start-up clients in developing a basic set of standard form agreements (e.g., 1- and 2-way non-disclosure agreements, material transfer agreements, consulting agreements, etc.) to multi-million dollar strategic collaboration agreements. His expertise in this area includes not only drafting definitive agreements, but also in the strategic conception and negotiation of the relevant business and legal documents.
Outside of the practice of law, Dan enjoys spending time with his wife and children, automobiles and racing, exercising regularly, woodworking, and traveling. He has also co-founded two privately held life sciences companies. He can be reached directly at 858.350.9690 or firstname.lastname@example.org.
Mike was formerly Vice President of Intellectual Properties for Biosite Incorporated, leaving at the end of 2007 following Biosite's acquisition by Inverness Medical Innovations for $1.6B. While at Biosite, Mike was responsible for strategic guidance and direction with regard to worldwide intellectual property issues, including, invention disclosures, patent applications, corporate trade secrets, domain names, copyrights and trademarks, and also served as a general corporate legal advisor. Prior to joining Biosite, Mike worked in the intellectual property group at the law firm of Foley & Lardner.
Mike received his law degree from the University of San Diego in 2000, from which he graduated magna cum laude. While completing his legal training, Mike also worked as a patent agent and law clerk at the law firms of Lyon & Lyon and Brobeck, Phleger & Harrison.
Mike brings an extensive background in biology and chemistry to his practice of law. He received a bachelor’s degree in biological sciences from the University of California, Irvine, followed by a master’s degree in biochemistry from the University of Colorado Health Sciences Center in 1983. He subsequently spent fifteen years as a biomedical researcher, and is an author on 20 peer reviewed scientific articles and numerous meeting abstracts, including publications in the journals Science, Nature, Cell, and the Journal of Molecular Biology.
Mike can be reached directly at 619.203.3186 or email@example.com.
Jim is a registered patent attorney with over 12 years experience in the procurement and strategic management of intellectual property. He has had the opportunity to represent clients in a wide variety of technologies, with an emphasis in the areas of biotechnology, pharmaceuticals, chemicals, and medical devices. He has extensive experience with the international prosecution of patents as well as post-issuance proceedings in the U.S. Jim also counsels clients on business transactions relating to intellectual property, including licensing and drafting of agreements (e.g., confidentiality agreements, material transfer agreements, consulting agreements, collaboration and sponsored research agreements, etc.). Jim received his Ph.D. in the Department of Biological Chemistry at U.C. Irvine in 1993, where his doctoral thesis focused on utilizing molecular biology and biochemical approaches to study the role of tyrosine kinases in signal transduction during early neuronal development. Jim received his law degree from The Southwestern University School of Law in 1998, and is admitted to practice law in California.
Jim has worked in the corporate setting as an in-house attorney and as an associate at law firms. He has represented a variety of clients, including large corporations, small companies, start-ups, universities, and individual inventors. Prior to joining ALG in 2008, he served as the Director of Intellectual Property at Paramount BioSciences LLC. At Paramount BioSciences LLC, most easily described as a venture capital and biotechnology company startup breeder organization, Jim was responsible for IP due diligence, the strategic management of international patent portfolios, counseling the development team and senior management of affiliate companies on IP matters, and the negotiation and drafting of IP and related corporate agreements. Jim has also worked as an associate at the large general practice law firms Duane Morris LLP (2005-2007) and Buchanan Ingersoll LLP (2003-2005), as an in-house patent attorney at Amylin Pharmaceuticals (2002-2003), and as a law clerk and associate at the IP boutique law firm Sheldon & Mak (1997-2002). This range of experience has given Jim the ability to recognize and solve problems on a wide range of issues from a variety of perspectives.
Jim has worked with technologies that include antibodies and other areas of immunology, assays and diagnostics (e.g. fluorescent energy transfer), antisense and related technologies, chemistry (chemical detection, chemical synthesis, and small molecules), formulations, growth factors and related molecules, infectious diseases (antifungals, bacteriology, and virology), inflammatory disorders, medical devices, nucleic acids, metabolic disorders (e.g. diabetes), oncology, proteins and peptides, and other aspects of biotechnology. You can reach Jim directly at 858.729.3254 or firstname.lastname@example.org.
Doug is registered with the U.S. Patent and Trademark Office (since 1993) and admitted to the practice of law in California and Alabama. He has 15 years of diverse legal experience in law firm and corporate settings serving as in-house and outside counsel for patent, trademark, and copyright law issues.
Doug’s practice emphasizes seasoned knowledge in the drafting and prosecution of domestic and international patents in the biotechnology, biomedical, molecular biology, medical device and mechanical arts, providing general intellectual property management and patent portfolio strategy development, as well as freedom to operate and due diligence analysis, opinion letters, and litigation support counsel to start-up and late stage corporate clients.
Doug’s practice further includes drafting and negotiating IP-oriented domestic and international confidentiality, collaborative research, license, manufacturing, clinical, asset purchase, and miscellaneous service and employment agreements.
Prior to joining ALG Doug served as Director of Intellectual Property and Corporate Secretary of Inovio Biomedical Corporation. At Inovio, he was sole in-house counsel responsible for managing and strategizing the company’s intellectual property and contract portfolios and overseeing various company policies and procedures. Previously, Doug has practiced as patent and transactional counsel to clients of Lyon & Lyon, LLP and Brobeck, Phleger and Harrison, LLP in San Diego, and Bradley Arant Rose and White LLP in Birmingham, Alabama. Doug further has master’s degree in microbiology and over 10 years experience at the bench as a scientist at Amgen, Inc. (from 1981 to 1993). Doug can be reached directly at 760.815.7554 or email@example.com.
Nancy is a transactional and intellectual property lawyer with over 20 years of experience, gained in large law firms and in-house. She is currently providing fractional general counsel services for companies that are not yet large enough to need full-time, in-house counsel. She was a shareholder with the law firm of Buchanan Ingersoll. Before that, she served as Vice President and General Counsel for ActivX Biosciences and held several positions at Amylin Pharmaceuticals, most recently Vice President and General Counsel. Additionally, Nancy has provided legal support for Takeda San Diego and GE Capital Solutions Global Electronics Services. Prior to her in-house experience, Nancy was an associate with Lyon & Lyon and Brobeck, Phleger & Harrison and served as a judicial clerk for the Honorable David R. Thompson of the Ninth Circuit Court of Appeals. She received her J.D. from the University of Oregon, her MBA from the Rady School of Management at the University of California San Diego and her B.S. in zoology from the University of Wisconsin.
Nancy can be reached directly at 858.945.8719 or firstname.lastname@example.org.